Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells.

Hah N, Danko CG, Core L, Waterfall JJ, Siepel A, Lis JT, Kraus WL.

Cell. 2011 May 13;145(4):622-34. doi: 10.1016/j.cell.2011.03.042. Epub 2011 May 5. Erratum in: Cell. 2011 Jun 24;145(7):1156.

2.

Hormone-regulated transcriptomes: lessons learned from estrogen signaling pathways in breast cancer cells.

Hah N, Kraus WL.

Mol Cell Endocrinol. 2014 Jan 25;382(1):652-64. doi: 10.1016/j.mce.2013.06.021. Epub 2013 Jun 28. Review.

3.

Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.

Gu F, Hsu HK, Hsu PY, Wu J, Ma Y, Parvin J, Huang TH, Jin VX.

BMC Syst Biol. 2010 Dec 17;4:170. doi: 10.1186/1752-0509-4-170.

4.

AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.

Bhat-Nakshatri P, Wang G, Appaiah H, Luktuke N, Carroll JS, Geistlinger TR, Brown M, Badve S, Liu Y, Nakshatri H.

Mol Cell Biol. 2008 Dec;28(24):7487-503. doi: 10.1128/MCB.00799-08. Epub 2008 Oct 6.

5.

A transcriptional sketch of a primary human breast cancer by 454 deep sequencing.

Guffanti A, Iacono M, Pelucchi P, Kim N, Soldà G, Croft LJ, Taft RJ, Rizzi E, Askarian-Amiri M, Bonnal RJ, Callari M, Mignone F, Pesole G, Bertalot G, Bernardi LR, Albertini A, Lee C, Mattick JS, Zucchi I, De Bellis G.

BMC Genomics. 2009 Apr 20;10:163. doi: 10.1186/1471-2164-10-163.

6.

RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites.

Yamaga R, Ikeda K, Horie-Inoue K, Ouchi Y, Suzuki Y, Inoue S.

Horm Cancer. 2013 Aug;4(4):222-32. doi: 10.1007/s12672-013-0140-3. Epub 2013 Mar 23.

PMID:
23526455
7.

Systemic identification of estrogen-regulated genes in breast cancer cells through cap analysis of gene expression mapping.

Yamaga R, Ikeda K, Boele J, Horie-Inoue K, Takayama K, Urano T, Kaida K, Carninci P, Kawai J, Hayashizaki Y, Ouchi Y, de Hoon M, Inoue S.

Biochem Biophys Res Commun. 2014 May 9;447(3):531-6. doi: 10.1016/j.bbrc.2014.04.033. Epub 2014 Apr 16.

PMID:
24746470
8.

Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells.

Inoue A, Omoto Y, Yamaguchi Y, Kiyama R, Hayashi SI.

J Mol Endocrinol. 2004 Jun;32(3):649-61.

9.

TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.

Woodfield GW, Horan AD, Chen Y, Weigel RJ.

Cancer Res. 2007 Sep 15;67(18):8439-43.

10.

Estrogen and growth factor signaling pathway: basic approaches for clinical application.

Hayashi S, Sakamoto T, Inoue A, Yoshida N, Omoto Y, Yamaguchi Y.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):433-42.

PMID:
14623541
11.

Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.

Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q.

J Biol Chem. 2005 Dec 30;280(52):43188-97. Epub 2005 Oct 11.

12.

A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.

Williams C, Edvardsson K, Lewandowski SA, Ström A, Gustafsson JA.

Oncogene. 2008 Feb 7;27(7):1019-32. Epub 2007 Aug 13.

PMID:
17700529
13.

Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.

Putnik M, Zhao C, Gustafsson JÅ, Dahlman-Wright K.

Biochem Biophys Res Commun. 2012 Sep 14;426(1):26-32. doi: 10.1016/j.bbrc.2012.08.007. Epub 2012 Aug 10.

PMID:
22902638
14.

SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells.

Moore RL, Faller DV.

J Endocrinol. 2013 Feb 15;216(3):273-85. doi: 10.1530/JOE-12-0102. Print 2013 Mar.

15.

The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.

Wang C, Mayer JA, Mazumdar A, Brown PH.

Breast Cancer Res Treat. 2012 Jun;133(2):487-500. doi: 10.1007/s10549-011-1775-9. Epub 2011 Sep 24.

16.

Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.

Dutertre M, Gratadou L, Dardenne E, Germann S, Samaan S, Lidereau R, Driouch K, de la Grange P, Auboeuf D.

Cancer Res. 2010 May 1;70(9):3760-70. doi: 10.1158/0008-5472.CAN-09-3988. Epub 2010 Apr 20.

17.

Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.

Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M.

J Cell Physiol. 2004 Sep;200(3):440-50.

PMID:
15254972
18.

Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B.

Prenzel T, Begus-Nahrmann Y, Kramer F, Hennion M, Hsu C, Gorsler T, Hintermair C, Eick D, Kremmer E, Simons M, Beissbarth T, Johnsen SA.

Cancer Res. 2011 Sep 1;71(17):5739-53. doi: 10.1158/0008-5472.CAN-11-1896. Epub 2011 Aug 23.

19.

MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis.

Antoon JW, Martin EC, Lai R, Salvo VA, Tang Y, Nitzchke AM, Elliott S, Nam SY, Xiong W, Rhodes LV, Collins-Burow B, David O, Wang G, Shan B, Beckman BS, Nephew KP, Burow ME.

PLoS One. 2013 Aug 9;8(8):e69291. doi: 10.1371/journal.pone.0069291. eCollection 2013.

20.

Effects of oestrogen on microRNA expression in hormone-responsive breast cancer cells.

Ferraro L, Ravo M, Nassa G, Tarallo R, De Filippo MR, Giurato G, Cirillo F, Stellato C, Silvestro S, Cantarella C, Rizzo F, Cimino D, Friard O, Biglia N, De Bortoli M, Cicatiello L, Nola E, Weisz A.

Horm Cancer. 2012 Jun;3(3):65-78. doi: 10.1007/s12672-012-0102-1.

PMID:
22274890
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk